New Jersey Leads in Aggressive Lung Cancer Treatment, Yet Lags in Early Diagnoses

New Jersey United States of America
Black New Jerseyans and those from the Pacific Islands are less likely to receive treatment compared to white patients.
New Jersey is among the leading states for aggressive lung cancer treatment with surgery and high survival rates.
New Jersey ranks 38th for the prevalence of lung cancer screening, with less than 3% of the population assessed annually for the disease.
The five-year lung cancer survival rate increased by 22% in the five years between 2015 to 2019.

New Jersey is recognized as one of the leading states for aggressive lung cancer treatment with surgery, boasting high survival rates. This information comes from a report by the American Lung Association, which also highlights that the five-year lung cancer survival rate has seen a significant increase of 22% in the five years between 2015 to 2019. The survival rate now stands at 26.6% across all racial and ethnic groups.

However, the report also reveals that the state lags in early diagnoses, with less than 3% of the population assessed annually for the disease. This places New Jersey at 38th for the prevalence of lung cancer screening. The survival rates for lung cancer could potentially be higher if more people at high-risk received annual low-dose CT scans, which are an effective way to catch the disease early.

Racial disparities in care were also noted in the report. Black New Jerseyans and those from the Pacific Islands are less likely to receive treatment compared to white patients. In an effort to reduce these racial disparities in screening and treatment, the state is seeking to implement mobile testing.

In 2020, more than 3,100 New Jersey residents died of lung cancer, with death rates varying significantly by county. Among people of color, the survival rate increased by 17% in just two years (2017-2019), and now stands at 23.7%.

While the survival rates are improving, especially among historically marginalized communities of color, the low screening rates still leave many people at risk. The state is actively working towards reducing these disparities and improving early detection and treatment of lung cancer.


Confidence

100%

No Doubts Found At Time Of Publication

Sources

98%

  • Unique Points
    • New Jersey is among the leading states for aggressive lung cancer treatment with surgery and high survival rates.
    • Black New Jerseyans and those from the Pacific Islands are less likely to receive treatment compared to white patients.
    • More than 3,100 New Jersey residents died of lung cancer in 2020, with death rates varying significantly by county.
    • The state is seeking to reduce racial disparities in screening and treatment with mobile testing.
    • New Jersey ranks 38th for the prevalence of lung cancer screening, with less than 3% of the population assessed annually for the disease.
  • Accuracy
    No Contradictions at Time Of Publication
  • Deception (100%)
    None Found At Time Of Publication
  • Fallacies (100%)
    None Found At Time Of Publication
  • Bias (100%)
    None Found At Time Of Publication
  • Site Conflicts Of Interest (100%)
    None Found At Time Of Publication
  • Author Conflicts Of Interest (100%)
    None Found At Time Of Publication

98%

  • Unique Points
    • The five-year lung cancer survival rate increased by 22% in the five years between 2015 to 2019.
    • Among people of color, the survival rate increased by 17% in just two years (2017-2019), and now stands at 23.7%.
    • Survival rates for lung cancer could be higher if more people at high-risk got annual low-dose CT scans, which are an effective way to catch the disease early.
  • Accuracy
    No Contradictions at Time Of Publication
  • Deception (100%)
    None Found At Time Of Publication
  • Fallacies (100%)
    None Found At Time Of Publication
  • Bias (100%)
    None Found At Time Of Publication
  • Site Conflicts Of Interest (100%)
    None Found At Time Of Publication
  • Author Conflicts Of Interest (100%)
    None Found At Time Of Publication

94%

  • Unique Points
    • A report from Avalere reveals that up to 30 million of the most vulnerable Americans may lose Medicaid coverage due to flawed state reviews.
    • The Biden administration is accused of not effectively intervening.
    • The Biden administration is also launching a new initiative to address the longstanding neglect of women's health in research, led by First Lady Jill Biden.
  • Accuracy
    No Contradictions at Time Of Publication
  • Deception (100%)
    None Found At Time Of Publication
  • Fallacies (100%)
    None Found At Time Of Publication
  • Bias (90%)
    • The Biden administration is accused of not effectively intervening.
    • Site Conflicts Of Interest (100%)
      None Found At Time Of Publication
    • Author Conflicts Of Interest (100%)
      None Found At Time Of Publication